中文名称: | EB-3D | ||||
---|---|---|---|---|---|
英文名称: | EB-3D | ||||
别名: | EB-3D;1,1'-(((ethane-1,2-diylbis(oxy))bis(4,1-phenylene))bis(methylene))bis(4-(dimethylamino)pyridinium) bromide;1-[[4-[2-[4-[[4-(Dimethylamino)pyridin-1-ium-1-yl]methyl]phenoxy]ethoxy]phenyl]methyl]-N,N-dimethylp | ||||
CAS No: | 1839150-63-8 | 分子式: | C30H36Br2N4O2 | 分子量: | 644.44 |
CAS No: | 1839150-63-8 | ||||
分子式: | C30H36Br2N4O2 | ||||
分子量: | 644.44 |
基本信息
产品编号:E10344 |
|||||
产品名称:EB-3D |
|||||
CAS: |
1839150-63-8 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
六个月 |
||
分子量: |
644.44 |
-20℃ |
一个月 |
||
化学名: |
|
||||
Solubility (25°C) |
体外 |
DMSO |
50mg/mL (77.58mM) |
||
Ethanol |
15mg/mL (23.27mM) |
||||
Water |
25mg/mL (38.79mM) |
||||
体内(现配现用) |
|
|
|||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
1.5517mL |
7.7587mL |
15.5173mL |
5mM |
0.3103mL |
1.5517mL |
3.1035mL |
10mM |
0.1552mL |
0.7759mL |
1.5517mL |
50mM |
0.0310mL |
0.1552mL |
0.3103mL |
生物活性
产品描述 |
是有效的选择性胆碱激酶 α (ChoKα) 抑制剂,对 ChoKα1 的 IC50 值为 1μM。 |
|
靶点/IC50 |
ChoKα1 |
|
1μM |
||
体外研究 |
EB-3D displays (0-100μM;72 hours) excellent antiproliferative activity against a wide cohort of T-leukemic cell lines,with GI GI50s 13 values in the nanomolar range.EB-3D (1.25-5μM;24 hours) induced apoptosis in leukemia cell lines.EB-3D (0.5-1μM;24 hours) induces a G0/G1 arrest that lead to apoptosis.EB-3D (0.3μM;48 hours) shows a first spike of activation of AMPKα after 30 minutes and a later increase in the phosphorylation of T172.EB-3D (1-40μM;48 hours) inhibits cell growth in HepG2 cells with a GI50 of 14.55μM.EB-3D induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells. Cell Proliferation Assay |
|
Cell Line: |
JURKAT,CCRF-CEM,HSB-2,MOLT-16,DNA-41,LOUCY,PEER,ALL-SIL cells |
|
Concentration: |
0.001,0.01,0.1,1,10,100μM |
|
Incubation Time: |
72 hours |
|
Result: |
Inhibited JURKAT,CCRF-CEM,HSB-2,MOLT-16,DNA-41,LOUCY,PEER,and ALL-SIL cells growth with GI50s of 136.2,478.8,17.7,0.9,60.6,200,265,and 132nM,respectively. |
|
Apoptosis Analysis |
||
Cell Line: |
Jurkat, CCRF-CEM and HSB-2 cells |
|
Concentration: |
1.25,2.5,5μM |
|
Incubation Time: |
24 hours |
|
Result: |
Induced apoptosis in leukemia cell lines. |
|
Cell Cycle Analysis |
||
Cell Line: |
Jurkat, CCRF-CEM and HSB-2 cells |
|
Concentration: |
0.5,1μM |
|
Incubation Time: |
24 hours |
|
Result: |
Induces cell cycle arrest in G0/G1 phase. |
|
Western Blot Analysis |
||
Cell Line: |
Jurkat cells |
|
Concentration: |
0.3μM |
|
Incubation Time: |
48 hours |
|
Result: |
Showed a first spike of activation of AMPKα after 30 minutes of treatment and a later increase in the phosphorylation of T172.The increase in S79 phosphorylation of its main target ACC (acetyl-coenzyme A (CoA) carboxylase),followed the same pattern.This rapid activation of AMPK,in turn induced a consequent reduction in mTOR phosphorylation that is visible already at 30’and that becomes amplified at longer time probably due to the interruption of feedback loops that are characteristic of mTOR connecting pathways. |
|
体内研究 |
EB-3D (1mg/kg;i.p.;every other day) impairs mammary tumor growth in syngeneic orthotopic E0771-C57BL/6 mouse model.EB-3D (2.5mg/kg; every other day for 4 weeks) shows a reduction of the number of spontaneous lung macro- and micrometastasis. |
|
Animal Model: |
E0771-C57BL/6 mice |
|
Dosage: |
I.p.;every other day for 4 weeks |
|
Administration: |
2.5mg/kg |
|
Result: |
A reduction of the number of spontaneous lung macro-and micrometastasis. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )